Form 4: CERUS Legal Officer Sells 55,000 Shares Under 10b5-1 Plan

Chrystal Jensen, Chief Legal Officer of CERUS Corp, sold 55,000 shares of common stock at $1.7 per share under a pre-arranged 10b5-1 plan.

Summary

• Chrystal Jensen, the Chief Legal Officer of CERUS CORP (CERS), reported a transaction involving the sale of company common stock.
• On November 24, 2025, Jensen disposed of 55,000 shares of Common Stock.
• The shares were sold at a price of $1.7 per share.
• This transaction was executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.
• Following this transaction, Jensen beneficially owns 728,294 shares of CERUS CORP Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly negative. While an insider sale can be perceived negatively, the fact that it was executed under a Rule 10b5-1 plan mitigates the negative signal, as it indicates a pre-scheduled transaction rather than a reaction to new information.

Negatives

• An insider sale, even under a 10b5-1 plan, can sometimes be perceived by the market as a slight negative signal, though less so than an open market sale without a pre-arranged plan.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide broader industry context or trends. It reflects an individual executive's pre-planned stock sale rather than a company-wide strategic move.

Stakeholder Impact

• Shareholders may observe this transaction as part of an executive's personal financial management. Given it's a 10b5-1 plan, the impact on shareholder confidence is likely minimal compared to an unscheduled open market sale.

Key Dates

Recommendation

The insider sale by the Chief Legal Officer, while a disposition of shares, was conducted under a pre-arranged 10b5-1 plan. This suggests the sale is part of a long-term financial strategy rather than a reaction to new, adverse company-specific information. Therefore, this single transaction alone does not warrant a change in investment recommendation, and a 'hold' stance is maintained, pending further fundamental analysis of the company's performance and outlook.

Keywords

CERUS CORP, CERS, Insider Transaction, Form 4, Stock Sale, Chrystal Jensen, Chief Legal Officer, 10b5-1 Plan